MiRus Announces Appointment of Angela Coldwell as Chief Financial Officer

ATLANTA, Aug. 2, 2021 /PRNewswire/ — MiRus™ announced today that Angela Coldwell has joined the company’s Leadership Team as Chief Financial Officer effective July 6, 2021. 

Mrs. Coldwell has most recently served as the chief financial officer of Aptitude Health, a global provider of oncology insights for the life science industry. She has over 25 years experience in finance and accounting with a focus in healthcare for the past decade. Mrs. Coldwell has led numerous debt and equity financings, investors relations, treasury operations and M&A transactions.

“It’s an exciting time to join MiRus,” said newly appointed CFO, Angela Coldwell. “As a leader in innovation in the medical device space, MiRus is seeing tremendous growth. I look forward to contributing to the continuing success of the company.”

Jay S. Yadav MD, Founder and CEO stated, “We are excited to welcome Angela to MiRus.  Her wealth of knowledge and experience will be invaluable in helping MiRus advance our financial systems and achieve important milestones.”

Previously, Mrs. Coldwell served as the senior director of finance at Curant Health, a specialty pharmacy and medication management group. Mrs. Coldwell is a chartered certified account receiving her degree from Manchester University in U.K.

About MiRus, LLC.
MiRus is a life science company head quartered in Marietta, Georgia that has developed and is commercializing proprietary novel biomaterials, implants and procedural solutions for the treatment spine, orthopaedic and structural heart disease. Find out more information about MiRus at

MiRus™ is a trademark of MiRus, LLC.

Pam Cowart
Vice President, Clinical Affairs, Compliance and Human Resources 


Related Links

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button